Literature DB >> 6345014

Epidemic group C meningococcal meningitis in Upper Volta, 1979.

C V Broome, M A Rugh, A A Yada, L Giat, H Giat, J M Zeltner, W R Sanborn, D W Fraser.   

Abstract

Group C meningococci were isolated during an epidemic of meningococcal meningitis which occurred between January and May 1979 in eastern Upper Volta, an area previously associated with endemic and epidemic group A disease. A total of 539 cases of meningitis, 55 of which were fatal, were reported, giving an attack rate of 517 cases per 100 000 inhabitants. Attack rates were higher for children under 15 years of age. Clinical and bacteriological data suggested that the group C meningococci were sulfonamide-resistant. The last meningococcal epidemic in Upper Volta occurred in 1970 and was nationwide. Epidemic cycles of group A meningococcal meningitis have occurred at 10-15 year intervals in the sub-Saharan region, raising concern that the current increase in activity may presage more wide-spread disease in the next dry season.

Entities:  

Mesh:

Year:  1983        PMID: 6345014      PMCID: PMC2536118     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  A Severe Epidemic of Meningococcus Meningitis in Chile, 1941-1942.

Authors:  M Pizzi
Journal:  Am J Public Health Nations Health       Date:  1944-03

2.  Meningococcal meningitis in northern Ghana: epidemiology and control measures.

Authors:  D W Belcher; A C Sherriff; K P Nimo; G L Chew; W D Richardson; A Voros; H A Feldman; W D Richardson; H A Feldman
Journal:  Am J Trop Med Hyg       Date:  1977-07       Impact factor: 2.345

3.  Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.

Authors:  T A Hoffman; E A Edwards
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

4.  [A new strategy of fight against meningococcal meningitis epidemics in Sahelian Africa].

Authors:  P Saliou; J L Rey; P H Stoeckel
Journal:  Bull Soc Pathol Exot Filiales       Date:  1978 Jan-Feb

5.  An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features.

Authors:  B M Greenwood; A K Bradley; P G Cleland; M H Haggie; M Hassan-King; L S Lewis; J T Macfarlane; A Taqi; H C Whittle; A M Bradley-Moore; Q Ansari
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

6.  Epidemic disease due to serogroup C Neisseria meningitidis in Saõ Paulo, Brazil.

Authors:  J Souza de Morais; R S Munford; J B Risi; E Antezana; R A Feldman
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

7.  Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population.

Authors:  A B Kaiser; C H Hennekens; M S Saslaw; P S Hayes; J V Bennett
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

8.  Trial of chloramphenicol for meningitis in northern savanna of Africa.

Authors:  H C Whittle; N M Davidson; B M Greenwood; D A Warrell; A Tomkins; P Tugwell; A Zalin; A D Bryceson; E H Parry; M Brueton; M Duggan; A D Rajković
Journal:  Br Med J       Date:  1973-08-18

9.  Control of meningococcal infection in the African meningitis belt by selective vaccination.

Authors:  B M Greenwood; S S Wali
Journal:  Lancet       Date:  1980-04-05       Impact factor: 79.321

10.  Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland.

Authors:  H Peltola
Journal:  Scand J Infect Dis       Date:  1978
View more
  25 in total

Review 1.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 2.  Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.

Authors:  Idris Mohammed; Garba Iliyasu; Abdulrazaq Garba Habib
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

3.  The changing face of meningococcal disease in West Africa.

Authors:  B Greenwood
Journal:  Epidemiol Infect       Date:  2007-07       Impact factor: 2.451

4.  Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influenzae type b in Sudanese and Swedish children.

Authors:  M A Salih; H Fredlund; S Hugosson; L Bodin; P Olcén
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

5.  Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Authors:  Danny Altmann; Abraham Aseffa; Margaret Bash; Nicole Basta; Ray Borrow; Claire Broome; Dominique Caugant; Tom Clark; Jean-Marc Collard; Mamoudou Djingarey; David Goldblatt; Brian Greenwood; Ulla Griffiths; Rana Hajjeh; Musa Hassan-King; Stephane Hugonnet; Ann Marie Kimball; Marc LaForce; Calman MacLennan; Martin C J Maiden; Olivier Manigart; Leonard Mayer; Nancy Messonnier; Jennifer Moisi; Katie Moore; Daugla Doumagoum Moto; Judith Mueller; Maria Nascimento; Stephen Obaro; Rasmata Ouedraogo; Anne-Laure Page; Willima Perea; Gerd Pluschke; Mari-Pierre Preziosi; Samba Sow; David Stephens; James Stuart; Madeleiene Thomson; Sylvestre Tiendrebeogo; Jean-Francois Trape; Guy Vernet
Journal:  Vaccine       Date:  2012-12-27       Impact factor: 3.641

6.  Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa.

Authors:  Sarah A Meyer; Ryan T Novak
Journal:  Lancet Infect Dis       Date:  2017-05-22       Impact factor: 25.071

Review 7.  Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.

Authors:  David Pace; Andrew J Pollard
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

8.  Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.

Authors:  Caroline L Trotter; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Sita S Kroman; Regina S Idohou; Oumarou Sanou; Leah Bowen; Helen Findlow; Serge Diagbouga; Bradford D Gessner; Ray Borrow; Judith E Mueller
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

9.  Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.

Authors:  Fati Sidikou; Caelin C Potts; Maman Zaneidou; Sarah Mbaeyi; Goumbi Kadadé; Marietou F Paye; Sani Ousmane; Bassira Issaka; Alexander Chen; How-Yi Chang; Djibo Issifou; Clement Lingani; Souleymane Sakande; Baruani Bienvenu; Ali Elhadji Mahamane; Alpha Oumar Diallo; Amadou Moussa; Issaka Seidou; Moussa Abdou; Ali Sidiki; Omar Garba; Sani Haladou; Jean Testa; Ricardo Obama Nse; Halima Boubacar Mainassara; Xin Wang
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226

10.  Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.

Authors:  Fati Sidikou; Maman Zaneidou; Ibrahim Alkassoum; Stephanie Schwartz; Bassira Issaka; Ricardo Obama; Clement Lingani; Ashley Tate; Flavien Ake; Souleymane Sakande; Sani Ousmane; Jibir Zanguina; Issaka Seidou; Innocent Nzeyimana; Didier Mounkoro; Oubote Abodji; Xin Wang; Muhamed-Kheir Taha; Jean Paul Moulia-Pelat; Assimawe Pana; Goumbi Kadade; Olivier Ronveaux; Ryan Novak; Odile Ouwe Missi Oukem-Boyer; Sarah Meyer
Journal:  Lancet Infect Dis       Date:  2016-08-23       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.